This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rupnow, B. A. Articles by Knox, S. J. Search for Related Content PubMed PubMed Citation Articles by Rupnow, B. A. Articles by Knox, S. J.

Direct Evidence That Apoptosis Enhances Tumor Responses to Fractionated Radiotherapy¹

Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305-5302

Currently, the contribution of cellular apoptotic sensitivity to tumor response after radiation therapy remains controversial. To address this issue, the survival of Rat-1 fibroblasts containing a 4-hydroxytamoxifenregulated c-Myc allele, c-MycER (T. D. Littlewood et al., Nucleic Acids Res., 23: 1686–1690, 1995), after single and fractionated doses of radiation was investigated. This model system allows pharmacological regulation of apoptosis sensitivity in the same cells in vitro and as xenograft tumors derived from these cells in vivo (G. I. Evan et al., Cell, 69: 119–128, 1992; R. M. Alarcon et al., Cancer Res., 56: 4315–4319, 1996). Activating c-MycER in vitro resulted in marked sensitization of Rat-1 fibroblasts to the effects of both single-dose and fractionated irradiation as measured by the induction of apoptosis and clonogenic survival. Overexpression of the antiapoptosis protein Bcl-2 suppressed the induction of apoptosis and increased clonogenic survival in cells with activated c-Myc after singledose and fractionated radiation. Systemic time-release implant delivery of 4-hydroxytamoxifen to severe combined immunodeficient mice bearing Rat-1-MycER tumors over the course of either single-dose (10 Gy) or fractionated (five fractions of 2 Gy) radiotherapy resulted in prolonged tumor growth delay relative to identical tumors from mice that received placebo implants. Furthermore, tumors derived from Rat-1-MycER cells that overexpressed Bcl-2 exhibited shorter tumor growth delays relative to similarly treated Rat-1-MycER tumors. The length of tumor growth delay after single-dose or fractionated radiotherapy strongly correlated with the extent of radiation-induced apoptosis in the xenograft tumors as measured by terminal deoxynucleotidyl transferase-mediated nick end labeling. These in vivo results provide direct evidence that increasing the sensitivity of tumor cells to die by apoptosis increases the efficacy of fractionated radiotherapy by reducing tumor cell clonogenic survival.

¹ Supported by NIH Grant CA68149 (to S. J. K.), a Howard Hughes Medical Institute Young Investigator Award (to A. J. G.), NIH Grant CA64489-01 (to A. J. G.), NIH Grant CA73832-01 (to A. J. G.), and American Cancer Society, California Division, Oncology Grant OPG-7-97 (to B. A. R.). B. A. R. is a Howard Hughes Medical Institute Predoctoral Fellow. A. D. M is an R. S. McLaughlin Fellow.

² To whom requests for reprints should be addressed, at Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305-5105. Phone: (415)725-4796; Fax: (415)725-8231.

Received 2/10/98. Accepted 3/16/98.

This article has been cited by other articles:

				I. Verbrugge, E. H.J. Wissink, R. W. Rooswinkel, J. Jongsma, N. Beltraminelli, M. Dupuis, J. Borst, and M. Verheij Combining Radiotherapy with APO010 in Cancer Treatment Clin. Cancer Res., March 15, 2009; 15(6): 2031 - 2038. [Abstract] [Full Text] [PDF]

				K. W. Yip, J. D. Mocanu, P.Y. B. Au, G. T. Sleep, D. Huang, P. Busson, W.-C. Yeh, R. Gilbert, B. O'Sullivan, P. Gullane, et al. Combination Bcl-2 Antisense and Radiation Therapy for Nasopharyngeal Cancer Clin. Cancer Res., November 15, 2005; 11(22): 8131 - 8144. [Abstract] [Full Text] [PDF]

				A. S. Allal, L. Waelchli, and M.-A. Brundler Prognostic Value of Apoptosis-Regulating Protein Expression in Anal Squamous Cell Carcinoma Clin. Cancer Res., December 15, 2003; 9(17): 6489 - 6496. [Abstract] [Full Text] [PDF]

				K. H. Maclean, U. B. Keller, C. Rodriguez-Galindo, J. A. Nilsson, and J. L. Cleveland c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-XL Mol. Cell. Biol., October 15, 2003; 23(20): 7256 - 7270. [Abstract] [Full Text] [PDF]

				S. W. Lowe and A. W. Lin Apoptosis in cancer Carcinogenesis, March 1, 2000; 21(3): 485 - 495. [Abstract] [Full Text] [PDF]

				H.-K. G. Shu, C. M. Julin, F. Furman, G. L. Yount, D. Haas-Kogan, and M. A. Israel Overexpression of E2F1 in glioma-derived cell lines induces a p53-independent apoptosis that is further enhanced by ionizing radiation Neuro-oncol, January 1, 2000; 2(1): 16 - 21. [Abstract] [PDF]

				J. M. Brown and B. G. Wouters Apoptosis, p53, and Tumor Cell Sensitivity to Anticancer Agents Cancer Res., April 1, 1999; 59(7): 1391 - 1399. [Abstract] [Full Text] [PDF]

				H. B. Forrester, C. A. Vidair, N. Albright, C. C. Ling, and W. C. Dewey Using Computerized Video Time Lapse for Quantifying Cell Death of X-irradiated Rat Embryo Cells Transfected with c-myc or c-Ha-ras Cancer Res., February 1, 1999; 59(4): 931 - 939. [Abstract] [Full Text] [PDF]